Invention Grant
- Patent Title: Methods for evaluating drug-resistance gene expression in the cancer patient
-
Application No.: US10299559Application Date: 2002-11-19
-
Publication No.: US07767390B2Publication Date: 2010-08-03
- Inventor: Michael S. Kopreski
- Applicant: Michael S. Kopreski
- Applicant Address: US NJ Long Valley
- Assignee: OncoMEDx, Inc.
- Current Assignee: OncoMEDx, Inc.
- Current Assignee Address: US NJ Long Valley
- Agency: McDonnell Boehnen Hulbert & Berghoff
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34
Abstract:
The methods of the invention detect in a qualitative or quantitative fashion drug-resistance RNA and DNA in blood plasma, serum, and other bodily fluids. The methods of the invention thereby enable the assessment of drug resistance in a neoplasm without the requirement of a tissue biopsy. The inventive methods are useful for the evaluation, monitoring, and selecting of drug treatment regimens, and for determining a predisposition for or prognosis of chemoresistant neoplastic disease.
Public/Granted literature
- US20030148345A1 Methods for evaluating drug-resistance gene expression in the cancer patient Public/Granted day:2003-08-07
Information query
